Results for tag: "Fluad QIV"

The Fluad QIV market is a segment of the Vaccines industry that focuses on the production and distribution of quadrivalent influenza vaccines. Quadrivalent influenza vaccines are designed to protect against four different strains of the influenza virus, two of which are of the A type and two of which are of the B type. These vaccines are typically administered to adults and children over the age of six months, and are recommended for annual use. The Fluad QIV market is highly competitive, with a number of companies offering their own versions of the vaccine. These companies include Sanofi Pasteur, GlaxoSmithKline, Seqirus, AstraZeneca, and Merck & Co. Show Less Read more